Lataa...
Evaluation of cytotoxicity of bevacizumab on VEGF-enriched corneal endothelial cells
PURPOSE: To evaluate the cytotoxicity of varying doses of Bevacizumab on corneal endothelial cells in the presence of a range of concentrations of vascular endothelial growth factor (VEGF). Bevacizumab, a drug widely used in the treatment of neovascular glaucoma neutralizes all isoforms of VEGF and...
Tallennettuna:
| Päätekijät: | , , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Molecular Vision
2011
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3247162/ https://ncbi.nlm.nih.gov/pubmed/22219629 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|